Authors:
Akunne, HC
Zoski, KT
Davis, MD
Cooke, LW
Meltzer, LT
Whetzel, SZ
Shih, YH
Wustrow, DJ
Wise, LD
MacKenzie, RG
Georgic, LM
Heffner, TG
Pugsley, TA
Citation: Hc. Akunne et al., PD 158771, a potential antipsychotic agent with D-2/D-3 partial agonist and 5-HT1A agonist actions. I. Neurochemical effects, NEUROPHARM, 39(7), 2000, pp. 1197-1210
Authors:
Corbin, AE
Meltzer, LT
Ninteman, FW
Wiley, JN
Cristoffersen, CL
Wustrow, DJ
Wise, LD
Pugsley, TA
Heffner, TG
Citation: Ae. Corbin et al., PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions. II. Preclinical behavioral effects, NEUROPHARM, 39(7), 2000, pp. 1211-1221
Authors:
Schelkun, RM
Yuen, PW
Serpa, K
Meltzer, LT
Wise, LD
Whittemore, ER
Woodward, RM
Citation: Rm. Schelkun et al., Subtype-selective N-methyl-D-aspartate receptor antagonists: Benzimidazalone and hydantoin as phenol replacements, J MED CHEM, 43(9), 2000, pp. 1892-1897
Authors:
van Vliet, LA
Rodenhuis, N
Wikstrom, H
Pugsley, TA
Serpa, KA
Meltzer, LT
Heffner, TG
Wise, LD
Lajiness, ME
Huff, RM
Svensson, K
Haenen, GRMM
Bast, A
Citation: La. Van Vliet et al., Thiazoloindans and thiazolobenzopyrans: A novel class of orally active central dopamine (partial) agonists, J MED CHEM, 43(19), 2000, pp. 3549-3557
Authors:
van Vliet, LA
Rodenhuis, N
Dijkstra, D
Wikstrom, H
Pugsley, TA
Serpa, KA
Meltzer, LT
Heffner, TG
Wise, LD
Lajiness, ME
Huff, RM
Svensson, K
Sundell, S
Lundmark, M
Citation: La. Van Vliet et al., Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D-3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907), J MED CHEM, 43(15), 2000, pp. 2871-2882
Authors:
Wright, JL
Gregory, TF
Boxer, PA
Meltzer, LT
Serpa, KA
Wise, LD
Citation: Jl. Wright et al., Discovery of subtype-selective nmda receptor ligands: 4-benzyl-1-piperidinyalkynylpyrroles, pyrazoles and imidazoles as NR1A/2B antagonists, BIOORG MED, 9(19), 1999, pp. 2815-2818
Authors:
Belliotti, TR
Wustrow, DJ
Brink, WA
Zoski, KT
Shih, YH
Whetzel, SZ
Georgic, LM
Corbin, AE
Akunne, HC
Heffner, TG
Pugsley, TA
Wise, LD
Citation: Tr. Belliotti et al., A series of 6-and 7-piperazinyl- and -piperidinylmethylbenzoxazinones withdopamine D4 antagonist activity: Discovery of a potential atypical antipsychotic agent, J MED CHEM, 42(25), 1999, pp. 5181-5187
Authors:
Kesten, SR
Heffner, TG
Johnson, SJ
Pugsley, TA
Wright, JL
Wise, LD
Citation: Sr. Kesten et al., Design, synthesis, and evaluation of chromen-2-ones as potent and selective human dopamine D4 antagonists, J MED CHEM, 42(18), 1999, pp. 3718-3725
Authors:
Zhou, ZL
Cai, SX
Whittemore, ER
Konkoy, CS
Espitia, SA
Tran, MT
Rock, DM
Coughenour, LL
Hawkinson, JE
Boxer, PA
Bigge, CF
Wise, LD
Weber, E
Woodward, RM
Keana, JFW
Citation: Zl. Zhou et al., 4-hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl) piperidine: A novel, potent, and selective NR1/2B NMDA receptor antagonist, J MED CHEM, 42(15), 1999, pp. 2993-3000